| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.0056 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0056 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.0045 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.0054 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0016 | 1 |